TA-35 ends Monday at 4,013.50 after 1.84% rise
Published on 11/09/2026 at 22:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTel Aviv closes higher
- The TA-35 finished Monday at 4,013.50 points, up 1.84% from Friday's close.
- Biomed and insurance shares led sector gains, while NextVision and El Al were prominent movers.
- Market breadth was positive, with 320 advancing stocks versus 149 decliners on the TASE.
The TA-35 ended Monday's Tel Aviv trading session at 4,013.50 points, a gain of 1.84% from Friday's close at 3,941.14. The session was already complete by the late-evening Berlin reporting slot, so the move is reported as a dated closing result rather than an intraday level.
Broad gains support the benchmark
Globes reported that the broader Tel Aviv market also advanced, with the TA-125 rising 1.97%. Within the sector landscape, the Biomed Index gained 3.4% and the Insurance Index increased 3.69%. The positive breadth was also notable: according to Investing.com, 320 stocks rose on the exchange, compared with 149 that fell, while 87 were unchanged.
NextVision and El Al lead movers
NextVision Stabilized Systems was the strongest performer among TA-35 constituents, rising 9.26% after reporting strong third-quarter results, according to Globes. OPC Energy gained 7.78% and Nova rose 7.39%, while Elbit Systems advanced 5.24%. El Al Israel Airlines climbed 5.39% on its debut in the TA-35, adding a new constituent-specific event to Monday's market backdrop.
The advance was not uniform. Azrieli Group declined 3.17%, NICE lost 3.08% and Ormat Technologies fell 2.53%, according to Investing.com. ICL and Delek Group also finished lower, with declines of 2.07% and 2.29%, respectively, as reported by Globes.
Index context for investors
The 1.84% rise represents a 72.36-point recovery from Friday's closing level. With gains concentrated across several influential sectors and market breadth clearly positive, Monday's close indicates broad participation rather than an advance limited to one index component. The next session's direction will depend on whether that participation persists and how investors assess fresh company results and index changes.
Further TA-35 coverage is available in the index topic section.
